Home » Topics » BioWorld Science

BioWorld Science
RSS

Exisulind reduces adenomatous colon polyps in clinical trial

Aug. 30, 2001

Virax to develop prostate cancer immunotherapy

Aug. 30, 2001

OSI Pharmaceuticals updates Tarceva development

Aug. 30, 2001

PH-10 enters phase I study for treatment of actininc keratosis

Aug. 30, 2001

Four centers added to Neotrofin Parkinson's disease trial

Aug. 30, 2001

Novel inhibitors of human CD23 and TNF release reported by GSK

Aug. 30, 2001

Avant replies to FDA's clinical hold of TP-10

Aug. 30, 2001

CV Therapeutics and Incyte advance cardiovascular genomics collaboration

Aug. 30, 2001

CollaGenex to market dental products from Atrix in the U.S.

Aug. 30, 2001

Orion and Pharmacia agree to develop antianxiety treatment for the U.S. market

Aug. 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...